Rebecca M. Luse
Independent DirectorMs. Rebecca M. Luse was Independent Director of Attovia Therapeutics, Inc. from March 31, 2025 to August 4, 2026. Ms. Luse is Director of Imbria Pharmaceuticals, Inc. from April 2025. Ms. Luse is Director of Halda Therapeutics, LLC from August 2024. Ms. Luse has served as Independent Director of LB Pharmaceuticals Inc since August 2023. She is Director at Oblenio Bio, Inc since June 2026. She serves as a Director at Halda Therapeutics Inc. Ms. Luse is Director of Mariana Oncology, Inc. since September 7, 2023. She is Managing Director of Deep Track Capital, LP since December 2024. She is Observer of the Advisory Board of Tubulis GmbH (formerly known as Tubulis Technologies). She served as Principal of Deep Track Capital, LP Since January 2021 until December 2024. She served as a Principal at New Leaf Venture Partners, L.L.C till 2021. Previously, she served as Vice President at the firm and served as Associate at the firm since joining in 2015. Ms. Luse focuses on biopharmaceuticals at the firm. She served as an Equity Associate and Research Senior Associate for Biotechnology at Jefferies LLC, Research Division. She served as a Research Analyst and Research Associate for Specialty Pharmaceuticals at Piper Jaffray Companies, Research Division. Ms. Luse covered specialty pharmaceuticals within the healthcare sector. She serves as a Board Member at Mariana Oncology, Inc. She served as an Analyst at Bay City Capital LLC. Ms. Luse served as a Healthcare Investment Banking Analyst at Banc of America Securities. She has been a board member and observer for several biotechnology companies. Previously, she spent many years on the sell side at both Jefferies and Piper Jaffray, covering biotechnology and specialty pharmaceuticals companies. She started her career as an investment banking analyst in the health care group of Bank of America and as a venture capital associate at Bay City Capital. She received a B.S. in Biochemistry and Mathematics, with minors in French and Economics, at Indiana University from 2002 to 2006.
公司職務
- 公司名稱LB Pharmaceuticals Inc股票代碼LBRX職務Independent Director共事同僚
- HDHeather D. TurnerCEO & Director
- SGScott GarlandIndependent Chairman of the Board
- GSGad SofferChief Operating & Business Officer
- JMJoseph M. MillerChief Financial Officer
- MPMinako PazderaGeneral Counsel
- LBLindsay BeaupreSenior VP of People & Culture
- JMJohn M. KaneChairman of Scientific Advisory Board
- RHRekha HemrajaniIndependent Director
